China-Focused Life Science Investor Acquires 37% of NovaBay for $28M Post author:Sam Post published:December 27, 2017 Post category:BioPharma After the transaction, it will be NovaBay’s largest shareholder with 6.6 million shares, 37% of the total. Source: BioSpace You Might Also Like Bay Area Bigfoot Biomedical Bags $37M Series B Financing December 18, 2017 Sanofi Appoints Executive Vice President Diabetes & Cardiovascular October 1, 2017 Abiomed Fourth Quarter Fiscal 2017 Earnings And Conference Call Notification April 12, 2017